According to A Latest intelligence report published by Market IntelliX, the global market for Monoclonal Antibody Biologics and Biosimilars should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Monoclonal Antibody Biologics and Biosimilars market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Monoclonal Antibody Biologics and Biosimilars market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Biologics segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Cancer has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Monoclonal Antibody Biologics and Biosimilars include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis and Merck, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.

This report aims to provide a comprehensive study of the global market for Monoclonal Antibody Biologics and Biosimilars. Report Highlights:

(1) Global Monoclonal Antibody Biologics and Biosimilars market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Monoclonal Antibody Biologics and Biosimilars market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Monoclonal Antibody Biologics and Biosimilars market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Monoclonal Antibody Biologics and Biosimilars segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Monoclonal Antibody Biologics and Biosimilars segment by type and by application and regional segment by type and by application.

(6) Monoclonal Antibody Biologics and Biosimilars industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Biologics

Biosimilars

Market segment by application, can be divided into

Cancer

Autoimmune Disease

Other

Market segment by players, this report covers

Roche

Amgen

AbbVie

Sanofi

Johnson & Johnson

Pfizer

Eli Lilly

Novartis

Merck

Biogen

Celltrion

Sobi

3SBIO

Innovent Biologics

1 Market Overview

1.1 Product Overview and Scope of Monoclonal Antibody Biologics and Biosimilars

1.2 Global Monoclonal Antibody Biologics and Biosimilars Market Size and Forecast

1.3 China Monoclonal Antibody Biologics and Biosimilars Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Monoclonal Antibody Biologics and Biosimilars Share in Global Market, 2018-2029

1.4.2 Monoclonal Antibody Biologics and Biosimilars Market Size: China VS Global, 2018-2029

1.5 Monoclonal Antibody Biologics and Biosimilars Market Dynamics

1.5.1 Monoclonal Antibody Biologics and Biosimilars Market Drivers

1.5.2 Monoclonal Antibody Biologics and Biosimilars Market Restraints

1.5.3 Monoclonal Antibody Biologics and Biosimilars Industry Trends

1.5.4 Monoclonal Antibody Biologics and Biosimilars Industry Policy

2 Global Competitive Situation by Company

2.1 Global Monoclonal Antibody Biologics and Biosimilars Revenue by Company (2018-2023)

2.2 Global Monoclonal Antibody Biologics and Biosimilars Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Monoclonal Antibody Biologics and Biosimilars Concentration Ratio

2.4 Global Monoclonal Antibody Biologics and Biosimilars Mergers & Acquisitions, Expansion Plans

2.5 Global Monoclonal Antibody Biologics and Biosimilars Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Monoclonal Antibody Biologics and Biosimilars Revenue by Company (2018-2023)

3.2 China Monoclonal Antibody Biologics and Biosimilars Monoclonal Antibody Biologics and Biosimilars Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Monoclonal Antibody Biologics and Biosimilars, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Monoclonal Antibody Biologics and Biosimilars Industry Chain

4.2 Monoclonal Antibody Biologics and Biosimilars Upstream Analysis

4.3 Monoclonal Antibody Biologics and Biosimilars Midstream Analysis

4.4 Monoclonal Antibody Biologics and Biosimilars Downstream Analysis

5 Sights by Type

5.1 Monoclonal Antibody Biologics and Biosimilars Classification

5.1.1 Biologics

5.1.2 Biosimilars

5.2 By Type, Global Monoclonal Antibody Biologics and Biosimilars Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029

6 Sights by Application

6.1 Monoclonal Antibody Biologics and Biosimilars Segment by Application

6.1.1 Cancer

6.1.2 Autoimmune Disease

6.1.3 Other

6.2 By Application, Global Monoclonal Antibody Biologics and Biosimilars Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Monoclonal Antibody Biologics and Biosimilars Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029

7.3 North America

7.3.1 North America Monoclonal Antibody Biologics and Biosimilars Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Monoclonal Antibody Biologics and Biosimilars Market Size Market Share

7.4 Europe

7.4.1 Europe Monoclonal Antibody Biologics and Biosimilars Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Monoclonal Antibody Biologics and Biosimilars Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Monoclonal Antibody Biologics and Biosimilars Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Monoclonal Antibody Biologics and Biosimilars Market Size Market Share

7.6 South America

7.6.1 South America Monoclonal Antibody Biologics and Biosimilars Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Monoclonal Antibody Biologics and Biosimilars Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Monoclonal Antibody Biologics and Biosimilars Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029

8.3.2 By Company, U.S. Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029

8.4.2 By Company, Europe Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029

8.5.2 By Company, China Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

8.5.3 By Type, China Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029

8.6.2 By Company, Japan Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029

8.7.2 By Company, South Korea Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029

8.9.2 By Company, India Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

8.9.3 By Type, India Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Roche

9.1.1 Roche Company Information, Head Office, Market Area and Industry Position

9.1.2 Roche Company Profile and Main Business

9.1.3 Roche Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.1.4 Roche Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.1.5 Roche Recent Developments

9.2 Amgen

9.2.1 Amgen Company Information, Head Office, Market Area and Industry Position

9.2.2 Amgen Company Profile and Main Business

9.2.3 Amgen Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.2.4 Amgen Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.2.5 Amgen Recent Developments

9.3 AbbVie

9.3.1 AbbVie Company Information, Head Office, Market Area and Industry Position

9.3.2 AbbVie Company Profile and Main Business

9.3.3 AbbVie Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.3.4 AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.3.5 AbbVie Recent Developments

9.4 Sanofi

9.4.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.4.2 Sanofi Company Profile and Main Business

9.4.3 Sanofi Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.4.4 Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.4.5 Sanofi Recent Developments

9.5 Johnson & Johnson

9.5.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

9.5.2 Johnson & Johnson Company Profile and Main Business

9.5.3 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.5.4 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.5.5 Johnson & Johnson Recent Developments

9.6 Pfizer

9.6.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.6.2 Pfizer Company Profile and Main Business

9.6.3 Pfizer Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.6.4 Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.6.5 Pfizer Recent Developments

9.7 Eli Lilly

9.7.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position

9.7.2 Eli Lilly Company Profile and Main Business

9.7.3 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.7.4 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.7.5 Eli Lilly Recent Developments

9.8 Novartis

9.8.1 Novartis Company Information, Head Office, Market Area and Industry Position

9.8.2 Novartis Company Profile and Main Business

9.8.3 Novartis Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.8.4 Novartis Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.8.5 Novartis Recent Developments

9.9 Merck

9.9.1 Merck Company Information, Head Office, Market Area and Industry Position

9.9.2 Merck Company Profile and Main Business

9.9.3 Merck Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.9.4 Merck Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.9.5 Merck Recent Developments

9.10 Biogen

9.10.1 Biogen Company Information, Head Office, Market Area and Industry Position

9.10.2 Biogen Company Profile and Main Business

9.10.3 Biogen Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.10.4 Biogen Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.10.5 Biogen Recent Developments

9.11 Celltrion

9.11.1 Celltrion Company Information, Head Office, Market Area and Industry Position

9.11.2 Celltrion Company Profile and Main Business

9.11.3 Celltrion Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.11.4 Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.11.5 Celltrion Recent Developments

9.12 Sobi

9.12.1 Sobi Company Information, Head Office, Market Area and Industry Position

9.12.2 Sobi Company Profile and Main Business

9.12.3 Sobi Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.12.4 Sobi Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.12.5 Sobi Recent Developments

9.13 3SBIO

9.13.1 3SBIO Company Information, Head Office, Market Area and Industry Position

9.13.2 3SBIO Company Profile and Main Business

9.13.3 3SBIO Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.13.4 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.13.5 3SBIO Recent Developments

9.14 Innovent Biologics

9.14.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position

9.14.2 Innovent Biologics Company Profile and Main Business

9.14.3 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

9.14.4 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

9.14.5 Innovent Biologics Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Monoclonal Antibody Biologics and Biosimilars Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Monoclonal Antibody Biologics and Biosimilars Market Restraints

Table 3. Monoclonal Antibody Biologics and Biosimilars Market Trends

Table 4. Monoclonal Antibody Biologics and Biosimilars Industry Policy

Table 5. Global Monoclonal Antibody Biologics and Biosimilars Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Company (2018-2023)

Table 7. Global Monoclonal Antibody Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Monoclonal Antibody Biologics and Biosimilars Mergers & Acquisitions, Expansion Plans

Table 9. Global Monoclonal Antibody Biologics and Biosimilars Manufacturers Product Type

Table 10. China Monoclonal Antibody Biologics and Biosimilars Revenue by Company (2018-2023) & (US$ million)

Table 11. China Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Monoclonal Antibody Biologics and Biosimilars Upstream (Raw Materials)

Table 13. Global Monoclonal Antibody Biologics and Biosimilars Typical Customers

Table 14. Monoclonal Antibody Biologics and Biosimilars Typical Distributors

Table 15. By Type, Global Monoclonal Antibody Biologics and Biosimilars Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Monoclonal Antibody Biologics and Biosimilars Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Monoclonal Antibody Biologics and Biosimilars Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Monoclonal Antibody Biologics and Biosimilars Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2029

Table 22. Roche Company Information, Head Office, Market Area and Industry Position

Table 23. Roche Company Profile and Main Business

Table 24. Roche Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 25. Roche Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 26. Roche Recent Developments

Table 27. Amgen Company Information, Head Office, Market Area and Industry Position

Table 28. Amgen Company Profile and Main Business

Table 29. Amgen Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 30. Amgen Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 31. Amgen Recent Developments

Table 32. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 33. AbbVie Company Profile and Main Business

Table 34. AbbVie Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 35. AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 36. AbbVie Recent Developments

Table 37. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 38. Sanofi Company Profile and Main Business

Table 39. Sanofi Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 40. Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 41. Sanofi Recent Developments

Table 42. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 43. Johnson & Johnson Company Profile and Main Business

Table 44. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 45. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 46. Johnson & Johnson Recent Developments

Table 47. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 48. Pfizer Company Profile and Main Business

Table 49. Pfizer Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 50. Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 51. Pfizer Recent Developments

Table 52. Eli Lilly Company Information, Head Office, Market Area and Industry Position

Table 53. Eli Lilly Company Profile and Main Business

Table 54. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 55. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 56. Eli Lilly Recent Developments

Table 57. Novartis Company Information, Head Office, Market Area and Industry Position

Table 58. Novartis Company Profile and Main Business

Table 59. Novartis Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 60. Novartis Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 61. Novartis Recent Developments

Table 62. Merck Company Information, Head Office, Market Area and Industry Position

Table 63. Merck Company Profile and Main Business

Table 64. Merck Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 65. Merck Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 66. Merck Recent Developments

Table 67. Biogen Company Information, Head Office, Market Area and Industry Position

Table 68. Biogen Company Profile and Main Business

Table 69. Biogen Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 70. Biogen Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 71. Biogen Recent Developments

Table 72. Celltrion Company Information, Head Office, Market Area and Industry Position

Table 73. Celltrion Company Profile and Main Business

Table 74. Celltrion Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 75. Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 76. Celltrion Recent Developments

Table 77. Sobi Company Information, Head Office, Market Area and Industry Position

Table 78. Sobi Company Profile and Main Business

Table 79. Sobi Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 80. Sobi Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 81. Sobi Recent Developments

Table 82. 3SBIO Company Information, Head Office, Market Area and Industry Position

Table 83. 3SBIO Company Profile and Main Business

Table 84. 3SBIO Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 85. 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 86. 3SBIO Recent Developments

Table 87. Innovent Biologics Company Information, Head Office, Market Area and Industry Position

Table 88. Innovent Biologics Company Profile and Main Business

Table 89. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application

Table 90. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023

Table 91. Innovent Biologics Recent Developments

List of Figure

Figure 1. Monoclonal Antibody Biologics and Biosimilars Picture

Figure 2. Global Monoclonal Antibody Biologics and Biosimilars Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Monoclonal Antibody Biologics and Biosimilars Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Monoclonal Antibody Biologics and Biosimilars Market Share of Global

Figure 5. Global Monoclonal Antibody Biologics and Biosimilars Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Monoclonal Antibody Biologics and Biosimilars Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Monoclonal Antibody Biologics and Biosimilars Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Monoclonal Antibody Biologics and Biosimilars Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Monoclonal Antibody Biologics and Biosimilars Industry Chain

Figure 10. Biologics

Figure 11. Biosimilars

Figure 12. By Type, Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, US$ Million

Figure 13. By Type, Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2029

Figure 14. Cancer

Figure 15. Autoimmune Disease

Figure 16. Other

Figure 17. By Application, Global Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, US$ Million

Figure 18. By Application, Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2029

Figure 19. By Region, Global Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2029

Figure 20. North America Monoclonal Antibody Biologics and Biosimilars Revenue & Forecasts, 2018-2029, US$ Million

Figure 21. By Country, North America Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

Figure 22. Europe Monoclonal Antibody Biologics and Biosimilars Revenue & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, Europe Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

Figure 24. Asia Pacific Monoclonal Antibody Biologics and Biosimilars Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country/Region, Asia Pacific Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

Figure 26. South America Monoclonal Antibody Biologics and Biosimilars Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country, South America Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2018-2023

Figure 28. Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. U.S. Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, (US$ Million)

Figure 30. By Company, U.S. Monoclonal Antibody Biologics and Biosimilars Market Share, 2018-2023

Figure 31. By Type, U.S. Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 32. By Application, U.S. Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 33. Europe Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, (US$ Million)

Figure 34. By Company, Europe Monoclonal Antibody Biologics and Biosimilars Market Share, 2018-2023

Figure 35. By Type, Europe Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 36. By Application, Europe Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 37. China Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, (US$ Million)

Figure 38. By Company, China Monoclonal Antibody Biologics and Biosimilars Market Share, 2018-2023

Figure 39. By Type, China Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 40. By Application, China Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 41. Japan Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, (US$ Million)

Figure 42. By Company, Japan Monoclonal Antibody Biologics and Biosimilars Market Share, 2018-2023

Figure 43. By Type, Japan Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 44. By Application, Japan Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 45. South Korea Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, (US$ Million)

Figure 46. By Company, South Korea Monoclonal Antibody Biologics and Biosimilars Market Share, 2018-2023

Figure 47. By Type, South Korea Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 48. By Application, South Korea Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 49. Southeast Asia Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, (US$ Million)

Figure 50. By Company, Southeast Asia Monoclonal Antibody Biologics and Biosimilars Market Share, 2018-2023

Figure 51. By Type, Southeast Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 52. By Application, Southeast Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 53. India Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, (US$ Million)

Figure 54. By Company, India Monoclonal Antibody Biologics and Biosimilars Market Share, 2018-2023

Figure 55. By Type, India Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 56. By Application, India Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 57. Middle East & Asia Monoclonal Antibody Biologics and Biosimilars Revenue, 2018-2029, (US$ Million)

Figure 58. By Company, Middle East & Asia Monoclonal Antibody Biologics and Biosimilars Market Share, 2018-2023

Figure 59. By Type, Middle East & Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 60. By Application, Middle East & Asia Monoclonal Antibody Biologics and Biosimilars Revenue Market Share, 2022 VS 2029

Figure 61. Research Methodology

Figure 62. Breakdown of Primary Interviews

Figure 63. Bottom-up Approaches

Figure 64. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)